TERBINAFINE HYDROCHLORIDE
Generic: TERBINAFINE TABLETS 250 MG
Cipla USA Inc.Manufacturer
ORALRoute
TERBINAFINE HYDROCHLORIDEActive Substance
2007-07-02Original Approval
TERBINAFINE HYDROCHLORIDE is FDA application ANDA077137, sponsored by CIPLA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
773 reports
2
RASH
479 reports
3
PRURITUS
405 reports
4
FATIGUE
374 reports
5
NAUSEA
359 reports
6
PAIN
332 reports
7
AGEUSIA
324 reports
8
OFF LABEL USE
313 reports
9
HEADACHE
285 reports
10
DIARRHOEA
273 reports